Abata Therapeutics to Present at Upcoming Investor and Industry Events in June
Abata Therapeutics Announces the Appointment of Leonard Dragone, M.D., Ph.D., as Chief Medical Officer
We Now Know the Enemy: A Conversation with Richard Ransohoff, M.D. Featuring John Maraganore, Ph.D.
Abata Therapeutics Appoints David Kaufman, M.D., Ph.D., to its Board of Directors
Abata Therapeutics Announces First Development Candidate, ABA-101, a Novel Treg Cell Therapy for the Treatment of Progressive Multiple Sclerosis